SCHEMBL4400649

SCHEMBL4400649

CC1CC(C)(C)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13957067 1.00
SCHEMBL20702296 1.00
SCHEMBL24355509 0.87 ALPL (0.44)
SCHEMBL22081048 0.87 ALPL (0.44)
SCHEMBL12940385 0.74
SCHEMBL12831127 0.74
SCHEMBL24350584 0.74 ALPL (0.39)
SCHEMBL18305942 0.72
SCHEMBL9941876 0.72
SCHEMBL15534229 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013177292-A1 TITANIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
WO-2013177269-A2 ZIRCONIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
WO-2013177284-A1 HAFNIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
US-20230348524-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2023-11-02 US disclosed
US-11434201-B2 Processes for preparing pyrrolidine compounds VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-09-06 US disclosed
US-20200369608-A1 PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2020-11-26 US disclosed
EP-3661915-A1 PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS Vertex Pharmaceuticals Incorporated (US) 2020-06-10 EP disclosed
CN-111051280-A Process for producing pyrrolidine compound 弗特克斯药品有限公司 2020-04-21 CN disclosed
WO-2019028228-A1 PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-02-07 WO disclosed
WO-2014082379-A9 SPIRO RING COMPOUND AS HEPATITIS C VIRUS (HCV) INHIBITOR AND USES THEREOF FIELD OF THE INVENTION SUNSHINE LAKE PHARMA CO.,LTD. (CN) 2016-02-25 WO disclosed
EP-2730572-B1 SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS SUNSHINE LAKE PHARMA CO LTD (CN) 2015-09-16 EP disclosed
EP-2730572-A1 SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS Sunshine Lake Pharma Co., Ltd (CN) 2014-05-14 EP disclosed
US-8637561-B2 Linked diimidazole derivatives ENANTA PHARMACEUTICALS, INC. (US) 2014-01-28 US disclosed
WO-2013177292-A1 TITANIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO disclosed
WO-2013177269-A2 ZIRCONIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO disclosed
WO-2013177284-A1 HAFNIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO disclosed
EP-2227479-B1 CYCLOPENTADIENYLPHOSPHAZENE COMPLEXES (CpPN COMPLEXES) OF METALS OF THE THIRD AND FOURTH GROUP AND OF THE LANTHANOIDS UNIV MARBURG PHILIPPS (DE) 2012-05-02 EP disclosed
US-20120076755-A1 Hepatitis C Virus Inhibitors ENANTA PHARMACEUTICALS, INC. 2012-03-29 US disclosed
US-20100226883-A1 LINKED DIIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. 2010-09-09 US disclosed
WO-2009068000-A2 CYCLOPENTADIENYLPHOSPHAZENE COMPLEXES (CpPN COMPLEXES) OF METALS OF THE THIRD AND FOURTH GROUP AND OF THE LANTHANOIDS PHILIPPS-UNIVERSITÄT MARBURG (DE) 2009-06-04 WO disclosed